Senti Biosciences
SNTI
SNTI
14 hedge funds and large institutions have $2.41M invested in Senti Biosciences in 2024 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 3 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less funds holding in top 10
Funds holding in top 10: →
60% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 10
74% less capital invested
Capital invested by funds: $9.17M → $2.41M (-$6.76M)
Holders
14
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$60.5K | |
| 2 | +$40.9K | |
| 3 | +$23.7K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$6.18K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$4.47K |
Top Sellers
| 1 | -$26K | |
| 2 | -$19.3K | |
| 3 | -$10.8K | |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$10.2K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$8.67K |